A detailed history of Wise Wealth Partners transactions in Eli Lilly & CO stock. As of the latest transaction made, Wise Wealth Partners holds 450 shares of LLY stock, worth $398,043. This represents 0.89% of its overall portfolio holdings.

Number of Shares
450
Previous 449 0.22%
Holding current value
$398,043
Previous $347 Million 7.17%
% of portfolio
0.89%
Previous 0.86%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 25, 2025

BUY
$725.72 - $929.72 $725 - $929
1 Added 0.22%
450 $372 Million
Q4 2024

Feb 14, 2025

BUY
$727.2 - $932.06 $326,512 - $418,494
449 New
449 $347 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $840B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Wise Wealth Partners Portfolio

Follow Wise Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wise Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Wise Wealth Partners with notifications on news.